Status:
RECRUITING
Prospective Clinico-biological Database of Patients With Ovarian and/or Peritoneal and/or Fallopian Tube Carcinoma
Lead Sponsor:
Centre Oscar Lambret
Conditions:
Cancer of the Ovary
Cancer of the Fallopian Tube
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Cancer of the ovary and/or peritoneum and/or fallopian tube have a very poor prognosis, and require the implementation of collaborative research tools and new innovative therapies. The main objective ...
Detailed Description
This study is part of the management of patients with advanced ovarian and/or peritoneal carcinoma, and/or fallopian tubes (initial treatment) at the Oscar Lambret Center. Once consent is obtained, re...
Eligibility Criteria
Inclusion
- Patient aged 18 or over
- Informed consent warranted
- Patient affiliated to a social security regimen
- Suspected or confirmed diagnosis of advanced and invasive ovarian cancer and/or primary peritoneal cancer and/or fallopian tube cancer (IIB to IV FIGO stages)
- Inclusion during standard care at the Oscar Lambret Centre, from diagnosis to the day of surgery
Exclusion
- Patient deprived of liberty or under curatorship or guardianship
- Refusal to participate
Key Trial Info
Start Date :
June 27 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 27 2032
Estimated Enrollment :
371 Patients enrolled
Trial Details
Trial ID
NCT06969833
Start Date
June 27 2025
End Date
June 27 2032
Last Update
June 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Oscar Lambret
Lille, France